- Cart 0
- English
Top-Tier Journal Approved: Absin mIHC Multiplex Service Unlocks the Code to High-Impact Papers
March 17, 2026
Clicks：75
Researchers, you know the struggle! Weak signal intensity, antibody species limitations, difficulty in multiplex co-staining... these pain points are major roadblocks to publishing high-impact papers!
Don't panic! Absin mIHC Multiplex Service is here to rescue your experiments with 6 years of experience and 500+ publications backing! We provide validated antibodies, automated scanning, and professional analysis—all in one comprehensive solution to overcome your experimental challenges and help you publish in top-tier journals!
✨ Why Choose Absin mIHC? Core Advantages Maximized
High Resolution, Enhanced Signal Intensity
· Superior resolution enabling precise detection of low-abundance targets
· Enhanced signal stability with reduced photobleaching for reliable experimental results
· Unrestricted primary antibody species compatibility—no more concerns about antibody cross-reactivity
· Multiplex staining capability supporting high-dimensional analysis to unlock complex cellular interaction networks
Full-Service Workflow, Unprecedented Convenience
✅ Antibodies Included: Pre-validated primary antibodies for immediate staining—saving you time on screening and validation
✅ Scanning Included: Leica automated staining system + Zeiss & 3D&TG whole-slide scanners for maximum imaging quality
✅ Analysis Included: HALO & StrataQuest image analysis software for professional data mining and visualization
✅ Flexible Customization: Supports simultaneous labeling of up to 30 markers with unlimited panel combinations and special research requirements accommodated
Rapid Turnaround, Accelerating Your Publication Timeline
Complete results delivered in as fast as 7 days—no more racing against experimental deadlines, allowing your research findings to be published first!
Comprehensive Marker Panels Covering All Research Domains
Whether your research focuses on immunology, oncology, neuroscience, or other fields, we have the appropriate marker combinations for you
|
Cell / Research Type |
Human (Free Antibodies) |
Mouse (Free Antibodies) |
Applicable Research Areas |
|
T Cells |
CD3, CD4, CD8, FOXP3, CD45, CD103, CD69 |
CD3, CD4, CD8, FOXP3, CD45, CD103, CD69 |
Immune cell infiltration, tumor immunotherapy |
|
Macrophages |
CD68, CD163, CD206, CD86, M-CSF, etc. |
F4/80, CD68, CD86, CD11b, CD163, etc. |
Inflammatory microenvironment, immune regulation |
|
Immune Checkpoints |
PD-1, PD-L1, HLA-DR, TIM-3, LAG-3, etc. |
GZMB, PD-1, PD-L1, TIM-3, LAG-3 |
Immune checkpoint inhibitor efficacy assessment |
|
Neural Cells |
IBA1, GFAP, NeuN |
IBA1, GFAP, NeuN |
Neurodegenerative diseases, neuroscience research |
|
Tumor-Associated |
Ki-67, PANCK, VEGF, EGFR, HER2, etc. |
SHP-2, Arginase-1, Ki-67, PANCK, etc. |
Tumor proliferation, angiogenesis, molecular subtyping |
|
NK Cells |
CD56, T-bet |
NKR-P1C(NK1.1), CD56, T-bet |
Innate immunity, anti-tumor immunity |
Real Case Demonstrations, Visible Results
Check out our panel examples—each image is publication-ready for your manuscript figures
· Human Lung Cancer 7-plex Panel: DAPI+CD3+CD20+Vimentin+Ki67+CD68+β-catenin
Clear chromatic distinction, precise cellular localization—complex spatial distributions of cell populations at a glance. Reviewers will be impressed!
Top-Tier Journal Validation, Proven Excellence
With 6 years of dedicated expertise, Absin mIHC Service has contributed to 500+ publications from collaborating institutions, with a cumulative impact factor exceeding 3000!
Collaborating institutions include: Tsinghua University, Peking University People's Hospital, Fudan University Cancer Hospital, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, The University of Hong Kong, Sichuan University West China Hospital, Nanjing Medical University, Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences, and other premier research institutions. Results have been published in top-tier journals including Signal Transduction and Targeted Therapy, Cancer Cell, and Cell:
IF=52.7: AD model mice achieved 45% Aβ clearance in brain within 2 hours, with cognitive improvement sustained for 6 months
IF=44.5: Revealed core mechanisms by which plasma cells regulate glioblastoma stem cells
IF=42.5: Achieved dual objectives of bacterial immunotherapy—"immune evasion + anti-tumor activation"
|
Item NO. |
Product Name |
Size |
|
Absin 4-Color IHC Kit (Anti-Rabbit and Mouse Secondary Antibody) |
20T/100T |
|
|
Absin 4-Color IHC Kit(Anti-Rabbit Secondary Antibody) |
20T/100T |
|
|
Absin 5-Color IHC Kit (Anti-Rabbit and Mouse Secondary Antibody) |
20T/100T |
|
|
Absin 5-Color IHC Kit (Anti-Rabbit Secondary Antibody) |
20T/100T |
|
|
Absin 6-Color IHC Kit (Anti-Rabbit and Mouse Secondary Antibody) |
20T/100T |
|
|
Absin 6-Color IHC Kit (Anti-Rabbit Secondary Antibody) |
20T/100T |
|
|
Absin 7-Color IHC Kit (Anti-Rabbit and Mouse Secondary Antibody) |
20T/100T |
|
|
Absin 7-Color IHC Kit(Anti-Rabbit Secondary Antibody) |
20T/100T |
|
|
Antibody eluent (for mIHC) |
30ml |
Contact Absin
Absin provides antibodies, proteins, ELISA kits, cell culture, detection kits, and other research reagents. If you have any product needs, please contact us.
| Absin Bioscience Inc. worldwide@absin.cn |
 Follow us on Facebook: Absin Bio |